Butyrate esterified to starch is released in the human gastrointestinal tract - PubMed (original) (raw)
Clinical Trial
. 2011 Nov;94(5):1276-83.
doi: 10.3945/ajcn.111.017228. Epub 2011 Sep 21.
Affiliations
- PMID: 21940597
- DOI: 10.3945/ajcn.111.017228
Free article
Clinical Trial
Butyrate esterified to starch is released in the human gastrointestinal tract
Julie M Clarke et al. Am J Clin Nutr. 2011 Nov.
Free article
Abstract
Background: Short-chain fatty acids (SCFAs) maintain human colonic function and may help prevent colonic disease. A study with ileostomists showed that starches acylated with specific SCFAs largely survive passage through the small intestine, but the percentage released in the colon has not been established.
Objective: The objective was to determine the percentage of ingested esterified butyrate released in the human gastrointestinal tract.
Design: The study was a randomized, crossover, controlled trial consisting of baseline and four 2-wk periods during which 16 volunteers consumed diets low in resistant starch plus 20 and 40 g cooked high-amylose maize starch (HAMS: HAMS20 or HAMS40) or butyrylated HAMS (HAMSB20 or HAMSB40) daily. HAMSB20 contained 31.8 mmol esterified butyrate. Complete 48-h fecal collections were made on days 2-3 and 12-13 of each period.
Results: Free fecal butyrate concentrations were higher after HAMSB40 than after HAMSB20 (P < 0.005) and HAMS (P < 0.0001) and higher than baseline data (P < 0.0001). Fecal esterified butyrate concentrations were highest in the HAMSB40 (days 12-13; P < 0.0001) group, and concentrations in the HAMSB40 (days 2-3) and HAMSB20 groups were higher than those in the HAMS groups and those at baseline (P < 0.0001). Ingestion of HAMSB20 and HAMSB40 resulted in the release of 26.8 ± 1.0 and 50.2 ± 2.4 mmol butyrate/d (days 12-13) (84.2 ± 3.0% and 79.0 ± 3.1% of total ingested esterified butyrate), respectively, in the gastrointestinal tract. By calculation, ∼57.2% of ingested esterified butyrate was released in the colon. Microbial analysis showed that this release was probably facilitated mainly by Parabacteroides distasonis, which increased in abundance with HAMSB40 (days 12-13) (P < 0.001).
Conclusions: This study shows that cooked butyrylated starch delivers esterified butyrate to the human colon effectively and has the potential to improve human bowel health. This trial is registered in the Australian Clinical Trials Registry as ACTRN012606000398505.
Similar articles
- Unraveling the gut health puzzle: exploring the mechanisms of butyrate and the potential of High-Amylose Maize Starch Butyrate (HAMSB) in alleviating colorectal disturbances.
Cheng J, Zhou J. Cheng J, et al. Front Nutr. 2024 Jan 18;11:1285169. doi: 10.3389/fnut.2024.1285169. eCollection 2024. Front Nutr. 2024. PMID: 38304546 Free PMC article. Review. - Excretion of starch and esterified short-chain fatty acids by ileostomy subjects after the ingestion of acylated starches.
Clarke JM, Bird AR, Topping DL, Cobiac L. Clarke JM, et al. Am J Clin Nutr. 2007 Oct;86(4):1146-51. doi: 10.1093/ajcn/86.4.1146. Am J Clin Nutr. 2007. PMID: 17921395 Clinical Trial. - Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated rats.
Toden S, Lockett TJ, Topping DL, Scherer BL, Watson EJ, Southwood JG, Clarke JM. Toden S, et al. Cancer Biol Ther. 2014;15(11):1515-23. doi: 10.4161/15384047.2014.955764. Cancer Biol Ther. 2014. PMID: 25482948 Free PMC article. - Butyrylated starch is less susceptible to enzymic hydrolysis and increases large-bowel butyrate more than high-amylose maize starch in the rat.
Bajka BH, Topping DL, Cobiac L, Clarke JM. Bajka BH, et al. Br J Nutr. 2006 Aug;96(2):276-82. doi: 10.1079/bjn20061807. Br J Nutr. 2006. PMID: 16923221 - Dietary resistant starch and chronic inflammatory bowel diseases.
Jacobasch G, Schmiedl D, Kruschewski M, Schmehl K. Jacobasch G, et al. Int J Colorectal Dis. 1999 Nov;14(4-5):201-11. doi: 10.1007/s003840050212. Int J Colorectal Dis. 1999. PMID: 10647628 Review.
Cited by
- Indole-3-Acetic Acid Esterified with Waxy, Normal, and High-Amylose Maize Starches: Comparative Study on Colon-Targeted Delivery and Intestinal Health Impact.
Gong Q, Qu X, Zhao Y, Zhang X, Cao S, Wang X, Song Y, Mackay CR, Wang Q. Gong Q, et al. Nutrients. 2024 Oct 11;16(20):3446. doi: 10.3390/nu16203446. Nutrients. 2024. PMID: 39458442 Free PMC article. - Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches.
Williams LM, Cao S. Williams LM, et al. Pharmacol Ther. 2024 Apr;256:108605. doi: 10.1016/j.pharmthera.2024.108605. Epub 2024 Feb 16. Pharmacol Ther. 2024. PMID: 38367866 Review. - Unraveling the gut health puzzle: exploring the mechanisms of butyrate and the potential of High-Amylose Maize Starch Butyrate (HAMSB) in alleviating colorectal disturbances.
Cheng J, Zhou J. Cheng J, et al. Front Nutr. 2024 Jan 18;11:1285169. doi: 10.3389/fnut.2024.1285169. eCollection 2024. Front Nutr. 2024. PMID: 38304546 Free PMC article. Review. - Morel (Morchella spp.) intake alters gut microbial community and short-chain fatty acid profiles in mice.
Pei L, Liu W, Liu L, Wang X, Jiang L, Chen Z, Wang Q, Wang P, Xu H. Pei L, et al. Front Nutr. 2023 Sep 22;10:1237237. doi: 10.3389/fnut.2023.1237237. eCollection 2023. Front Nutr. 2023. PMID: 37810928 Free PMC article. - The Impact of a 24-h Low and High Fermentable Oligo- Di- Mono-Saccharides and Polyol (FODMAP) Diet on Plasma Bacterial Profile in Response to Exertional-Heat Stress.
Gaskell SK, Henningsen K, Young P, Gill P, Muir J, Henry R, Costa RJS. Gaskell SK, et al. Nutrients. 2023 Jul 29;15(15):3376. doi: 10.3390/nu15153376. Nutrients. 2023. PMID: 37571312 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources